Mutational analysis of the hepatitis C virus E1 glycoprotein in retroviral pseudoparticles and cell-culture-derived H77/JFH1 chimeric infectious virus particles

Journal of Viral Hepatitis

Volumn 16, Issue 9, 2009, Pages 621-632

  Russell, R S ^a,d   Kawaguchi, K ^a   Meunier, J C ^a   Takikawa, S ^a   Faulk, K ^a   Bukh, J ^a,b,c   Purcell, R H ^a   Emerson, S U ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b Mental Health Services CPH   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

Glycoprotein; Glycosylation; HCV entry; HCVcc; HCVpp; Hepatitis C virus

Indexed keywords

ALANINE; CD81 ANTIGEN; GLYCOPROTEIN E1; GLYCOPROTEIN E2; PROLINE;

AMINO ACID SUBSTITUTION; ANTIGEN BINDING; ARTICLE; CONTROLLED STUDY; GENE MUTATION; GENOTYPE; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN GLYCOSYLATION; PROTEIN PROTEIN INTERACTION; VIRUS CELL INTERACTION; VIRUS INFECTIVITY; VIRUS PARTICLE; WILD TYPE;

AMINO ACID SUBSTITUTION; ANTIGENS, CD; CELL LINE; GENETIC VECTORS; HEPACIVIRUS; HUMANS; MUTAGENESIS, SITE-DIRECTED; MUTANT PROTEINS; PROTEIN BINDING; RECOMBINATION, GENETIC; RETROVIRIDAE; VIRAL ENVELOPE PROTEINS; VIRION; VIRUS INTERNALIZATION;

EID: 68949209321     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2009.01111.x     Document Type: Article

References (58)

1. Lindenbach BD, Rice CM. Flaviviridae: the viruses and their replication. In Knipe DM, Howley PM, eds. Fields Virology, Philadelphia : Lippincott Williams & Wilkins, 2001 : 991 1042.
2. Heinz FX, Allison SL. The machinery for flavivirus fusion with host cell membranes. Curr Opin Microbiol 2001 4 (4 450 455.
3. Kielian M. Class II virus membrane fusion proteins. Virology 2006 344 (1 38 47.
4. Kielian M, Rey FA. Virus membrane-fusion proteins: more than one way to make a hairpin. Nat Rev Microbiol 2006 4 (1 67 76.
5. Op De Beeck A, Montserret R, Duvet S et al. The transmembrane domains of hepatitis C virus envelope glycoproteins E1 and E2 play a major role in heterodimerization. J Biol Chem 2000 275 (40 31428 31437.
6. Bartosch B, Dubuisson J, Cosset FL. Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes. J Exp Med 2003 197 (5 633 642.
7. Drummer HE, Maerz A, Poumbourios P. Cell surface expression of functional hepatitis C virus E1 and E2 glycoproteins. FEBS Lett 2003 546 (2-3 385 390.
8. Hsu M, Zhang J, Flint M et al. Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles. Proc Natl Acad Sci USA 2003 100 (12 7271 7276.
9. Pileri P, Uematsu Y, Campagnoli S et al. Binding of hepatitis C virus to CD81. Science 1998 282 (5390 938 941.
10. Drummer HE, Poumbourios P. Hepatitis C virus glycoprotein E2 contains a membrane-proximal heptad repeat sequence that is essential for E1E2 glycoprotein heterodimerization and viral entry. J Biol Chem 2004 279 (29 30066 30072.
11. Kuhn RJ, Zhang W, Rossmann MG et al. Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell 2002 108 (5 717 725.
12. Flint M, Thomas JM, Maidens CM et al. Functional analysis of cell surface-expressed hepatitis C virus E2 glycoprotein. J Virol 1999 73 (8 6782 6790.
13. Ciccaglione AR, Costantino A, Marcantonio C, Equestre M, Geraci A, Rapicetta M. Mutagenesis of hepatitis C virus E1 protein affects its membrane-permeabilizing activity. J Gen Virol 2001 82 (Pt 9 2243 2250.
14. Perez-Berna AJ, Moreno MR, Guillen J, Bernabeu A, Villalain J. The membrane-active regions of the hepatitis C virus E1 and E2 envelope glycoproteins. Biochemistry 2006 45 (11 3755 3768.
15. Lavillette D, Pecheur EI, Donot P et al. Characterization of fusion determinants points to the involvement of three discrete regions of both E1 and E2 glycoproteins in the membrane fusion process of hepatitis C virus. J Virol 2007 81 (16 8752 8765.
16. Nakabayashi H, Taketa K, Miyano K, Yamane T, Sato J. Growth of human hepatoma cells lines with differentiated functions in chemically defined medium. Cancer Res 1982 42 (9 3858 3863.
17. Ma Y, Yates J, Liang Y, Lemon SM, Yi M. NS3 helicase domains involved in infectious intracellular hepatitis C virus particle assembly. J Virol 2008 82 (15 7624 7639.
18. Yi M, Ma Y, Yates J, Lemon SM. Compensatory mutations in E1, p7, NS2, and NS3 enhance yields of cell culture-infectious intergenotypic chimeric hepatitis C virus. J Virol 2007 81 (2 629 638.
19. Goffard A, Callens N, Bartosch B et al. Role of N-linked glycans in the functions of hepatitis C virus envelope glycoproteins. J Virol 2005 79 (13 8400 8409.
20. Lavillette D, Tarr AW, Voisset C et al. Characterization of host-range and cell entry properties of the major genotypes and subtypes of hepatitis C virus. Hepatology 2005 41 (2 265 274.
21. Ciczora Y, Callens N, Penin F, Pecheur EI, Dubuisson J. Transmembrane domains of hepatitis C virus envelope glycoproteins: residues involved in E1E2 heterodimerization and involvement of these domains in virus entry. J Virol 2007 81 (5 2372 2381.
22. Shimizu YK, Igarashi H, Kiyohara T et al. A hyperimmune serum against a synthetic peptide corresponding to the hypervariable region 1 of hepatitis C virus can prevent viral infection in cell cultures. Virology 1996 223 (2 409 412.
23. Higginbottom A, Quinn ER, Kuo CC et al. Identification of amino acid residues in CD81 critical for interaction with hepatitis C virus envelope glycoprotein E2. J Virol 2000 74 (8 3642 3649.
24. Zhong J, Gastaminza P, Cheng G et al. Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci USA 2005 102 (26 9294 9299.
25. Russell RS, Meunier JC, Takikawa S et al. Advantages of a single-cycle production assay to study cell culture-adaptive mutations of hepatitis C virus. Proc Natl Acad Sci USA 2008 105 (11 4370 4375.
26. Tellier R, Bukh J, Emerson SU, Miller RH, Purcell RH. Long PCR and its application to hepatitis viruses: amplification of hepatitis A, hepatitis B, and hepatitis C virus genomes. J Clin Microbiol 1996 34 (12 3085 3091.
27. Tellier R, Bukh J, Emerson SU, Purcell RH. Long PCR methodology. Methods Mol Biol 2003 226 : 173 178.
28. Yanagi M, Purcell RH, Emerson SU, Bukh J. Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee. Proc Natl Acad Sci USA 1997 94 (16 8738 8743.
29. Yanagi M, Purcell RH, Emerson SU, Bukh J. Hepatitis C virus: an infectious molecular clone of a second major genotype (2a) and lack of viability of intertypic 1a and 2a chimeras. Virol 1999 262 (1 250 263.
30. Russell CJ, Jardetzky TS, Lamb RA. Conserved glycine residues in the fusion peptide of the paramyxovirus fusion protein regulate activation of the native state. J Virol 2004 78 (24 13727 13742.
31. Wilson KA, Bar S, Maerz AL, Alizon M, Poumbourios P. The conserved glycine-rich segment linking the N-terminal fusion peptide to the coiled coil of human T-cell leukemia virus type 1 transmembrane glycoprotein gp21 is a determinant of membrane fusion function. J Virol 2005 79 (7 4533 4539.
32. Allison SL, Schalich J, Stiasny K, Mandl CW, Heinz FX. Mutational evidence for an internal fusion peptide in flavivirus envelope protein E. J Virol 2001 75 (9 4268 4275.
33. Op De Beeck A, Voisset C, Bartosch B et al. Characterization of functional hepatitis C virus envelope glycoproteins. J Virol 2004 78 (6 2994 3002.
34. Pizzato M, Marlow SA, Blair ED, Takeuchi Y. Initial binding of murine leukemia virus particles to cells does not require specific Env-receptor interaction. J Virol 1999 73 (10 8599 8611.
35. Sandrin V, Boulanger P, Penin F, Granier C, Cosset FL, Bartosch B. Assembly of functional hepatitis C virus glycoproteins on infectious pseudoparticles occurs intracellularly and requires concomitant incorporation of E1 and E2 glycoproteins. J Gen Virol 2005 86 (Pt 12 3189 3199.
36. Callens N, Ciczora Y, Bartosch B et al. Basic residues in hypervariable region 1 of hepatitis C virus envelope glycoprotein e2 contribute to virus entry. J Virol 2005 79 (24 15331 15341.
37. Ciczora Y, Callens N, Montpellier C et al. Contribution of the charged residues of hepatitis C virus glycoprotein E2 transmembrane domain to the functions of the E1E2 heterodimer. J Gen Virol 2005 86 (Pt 10 2793 2798.
38. Drummer HE, Boo I, Poumbourios P. Mutagenesis of a conserved fusion peptide-like motif and membrane-proximal heptad-repeat region of hepatitis C virus glycoprotein E1. J Gen Virol 2007 88 (Pt 4 1144 1148.
39. Masciopinto F, Campagnoli S, Abrignani S, Uematsu Y, Pileri P. The small extracellular loop of CD81 is necessary for optimal surface expression of the large loop, a putative HCV receptor. Virus Res 2001 2 : 1 10.
40. Meola A, Sbardellati A, Bruni Ercole B et al. Binding of hepatitis C virus E2 glycoprotein to CD81 does not correlate with species permissiveness to infection. J Virol 2000 74 (13 5933 5938.
41. Petracca R, Falugi F, Galli G et al. Structure-function analysis of hepatitis C virus envelope-CD81 binding. J Virol 2000 74 (10 4824 4830.
42. Owsianka AM, Timms JM, Tarr AW et al. Identification of conserved residues in the E2 envelope glycoprotein of the hepatitis C virus that are critical for CD81 binding. J Virol 2006 80 (17 8695 8704.
43. Allander T, Forns X, Emerson SU, Purcell RH, Bukh J. Hepatitis C virus envelope protein E2 binds to CD81 of tamarins. Virol 2000 277 (2 358 367.
44. Flint M, Maidens C, Loomis-Price LD et al. Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81. J Virol 1999 73 (8 6235 6244.
45. Cocquerel L, Kuo CC, Dubuisson J, Levy S. CD81-dependent binding of hepatitis C virus E1E2 heterodimers. J Virol 2003 77 (19 10677 10683.
46. Drummer HE, Wilson KA, Poumbourios P. Identification of the hepatitis C virus E2 glycoprotein binding site on the large extracellular loop of CD81. J Virol 2002 76 (21 11143 11147.
47. Rothwangl KB, Manicassamy B, Uprichard SL, Rong L. Dissecting the role of putative CD81 binding regions of E2 in mediating HCV entry: putative CD81 binding region 1 is not involved in CD81 binding. J Virol 2008 5 : 46.
48. Nakajima H, Cocquerel L, Kiyokawa N, Fujimoto J, Levy S. Kinetics of HCV envelope proteins' interaction with CD81 large extracellular loop. Biochem Biophys Res Commun 2005 328 (4 1091 1100.
49. Chanel-Vos C, Kielian M. A conserved histidine in the ij loop of the Semliki Forest virus E1 protein plays an important role in membrane fusion. J Virol 2004 78 (24 13543 13552.
50. Dubuisson J, Duvet S, Meunier JC et al. Glycosylation of the hepatitis C virus envelope protein E1 is dependent on the presence of a downstream sequence on the viral polyprotein. J Biol Chem 2000 275 (39 30605 30609.
51. Michalak JP, Wychowski C, Choukhi A et al. Characterization of truncated forms of hepatitis C virus glycoproteins. J Gen Virol 1997 78 (Pt 9 2299 2306.
52. Patel J, Patel AH, McLauchlan J. The transmembrane domain of the hepatitis C virus E2 glycoprotein is required for correct folding of the E1 glycoprotein and native complex formation. Virology 2001 279 (1 58 68.
53. Lindenbach BD, Evans MJ, Syder AJ et al. Complete replication of hepatitis C virus in cell culture. Science 2005 309 (5734 623 626.
54. Wakita T, Pietschmann T, Kato T et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 2005 11 (7 791 796.
55. Pietschmann T, Kaul A, Koutsoudakis G et al. Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras. Proc Natl Acad Sci USA 2006 103 (19 7408 7413.
56. Yi M, Villanueva RA, Thomas DL, Wakita T, Lemon SM. Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells. Proc Natl Acad Sci USA 2006 103 (7 2310 2315.
57. Meunier JC, Engle RE, Faulk K et al. Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1. Proc Natl Acad Sci USA 2005 102 (12 4560 4565.
58. Meunier JC, Russell RS, Engle RH, Faulk KN, Purcell RH, Emerson SU. Apolipoprotein C1 association with Hepatitis C Virus. J Virol 2008 82 (19 9647 9656.